McClarren Financial Advisors’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-165
Closed -$24K 101
2025
Q1
$24K Buy
+165
New +$23.9K 0.02% 178
2024
Q4
Sell
-162
Closed -$25 210
2024
Q3
$25 Buy
162
+123
+315% +$19.9K ﹤0.01% 158
2024
Q2
$25K Sell
39
-123
-76% -$18.5K 0.02% 198
2024
Q1
$22K Buy
162
+3
+2% +$397 0.02% 210
2023
Q4
$21K Hold
159
0.02% 229
2023
Q3
$21K Buy
+159
New +$21.7K 0.02% 211
2023
Q2
Sell
-159
Closed -$22K 338
2023
Q1
$22K Buy
159
+2
+1% +$269 0.02% 200
2022
Q4
$21K Hold
157
0.02% 205
2022
Q3
$17K Buy
+157
New +$19.9K 0.02% 203
2022
Q2
Sell
-156
Closed -$20K 50
2022
Q1
$20K Buy
156
+2
+1% +$240 0.01% 175
2021
Q4
$18K Buy
154
+1
+0.7% +$118 0.01% 195
2021
Q3
$18K Buy
153
+1
+0.7% +$116 0.01% 170
2021
Q2
$18K Hold
152
0.01% 186
2021
Q1
$15K Buy
152
+3
+2% +$302 0.01% 171
2020
Q4
$14K Buy
+149
New +$15.8K 0.01% 152

Other funds holding AZN